Physician profile
Claudiu Muresan
NPI 1225352081
$10,958.86
in general payments reported to CMS, 2019-2025
19 companies · $1,118 in 2025
The $1,118 reported for 2025 was more than what 77% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $2,313 · 2021: $5,203 · 2022: $270 · 2023: $1,481 · 2024: $438 · 2025: $1,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,654 · Travel and Lodging: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,653.90 |
| Travel and Lodging | $1,382.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $5,269.34 | 2020-2023 | |
| Arthrex, INC. | $2,115.20 | 2021-2025 | |
| Skeletal Dynamics INC | $741.08 | 2021-2023 | Geminus, Ijs, Align |
| Mid-Atlantic Surgical Systems, LLC | $636.77 | 2025 | |
| Medartis INC. | $620.87 | 2021-2024 | Aptus |
| Axogen | $446.01 | 2020-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Endo Pharmaceuticals INC. | $226.08 | 2019-2023 | Xiaflex |
| Acumed LLC | $197.83 | 2020-2023 | Acumed, Nanophix Implant |
| Checkpoint Surgical, INC | $153.45 | 2022 | |
| Allergan, INC. | $121.85 | 2019 | |
| Stryker Corporation | $108.66 | 2023-2025 | Hoffmann, Na, Universal Neuro 2 |
| Smith+Nephew, INC. | $69.47 | 2024-2025 | Oasis, Stravix Pl, Stravix |
| Endo USA, INC. | $59.38 | 2024-2025 | Xiaflex |
| Polynovo North America LLC | $50.09 | 2024 | Novosorb Btm |
| Bioventus LLC | $42.28 | 2024 | Exogen Ultrasound Bone Healing System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $28.95 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merz Pharmaceuticals, LLC | $25.63 | 2024 | Xeomin |
| Depuy Synthes Sales INC. | $23.37 | 2021 | |
| Kerecis Limited | $22.55 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudiu Muresan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.